Search For "biopharmaceuticals"
Biocon Q2FY23 Revenue at Rs 2,384 Cr., Up 23 percent; Core EBITDA at Rs 81
Updated : 3 years, 6 months ago IST
Bengaluru (Karnataka) [India], November 15 (ANI/NewsVoir): Biocon Ltd, an innovation-led global biopharmaceuticals company, today announced its consolidated financial results for the second quarter ended September 30, 2022.
Read More
NTAGI to discuss data of Gennova pharmaceuticals' indigenous mRNA vaccine
Updated : 3 years, 10 months ago IST
New Delhi [India], July 11 (ANI): The National Technical Advisory Group on Immunisation (NTAGI's) Covid working group is expected to conduct a meeting soon to discuss India's first mRNA vaccine against COVID and Biological E's Corbevax Booster dose for Covishield and Covaxin beneficiaries
Read More
If govt permits indigenous mRNA vaccine is ready to be roll out in 72 hou
Updated : 3 years, 11 months ago IST
New Delhi [India], June 29 (ANI): The company is ready to roll out India's first mRNA vaccine in 72 hours after the government's permission, said Gennova Biopharmaceuticals Ltd Chief Executive Officer and Whole-time Director Dr Sanjay Singh.
Read More
India's first mRNA vaccine by Gennova gets DCGI approval, to be rolled out
Updated : 3 years, 11 months ago IST
Pune (Maharashtra) [India], June 29 (ANI): India's first indigenously developed mRNA vaccine against the COVID-19 gets the Emergency Use Authorization (EUA), to be sold under the brand name GEMCOVAC™-19 and will be rolled out soon, informed the officials on Wednesday.
Read More
DCGI gives emergency use authorisation to India's first mRNA COVID-19 vacc
Updated : 3 years, 11 months ago IST
New Delhi [India], June 28 (ANI): The Drugs Controller General of India (DCGI) has approved two doses of Pune-based Gennova Biopharmaceuticals' mRNA COVID-19 vaccine for restricted use in emergency situations for beneficiaries aged above 18 years age group.
Read More
CDL Kasauli clears over 21 lakh mRNA COVID-19 vaccine doses: Sources
Updated : 4 years ago IST
New Delhi [India], May 13 (ANI): The Central Drugs Laboratory (CDL), Kasauli has cleared more than 21 lakh mRNA COVID-19 vaccine doses for stockpiling, the sources told ANI.
Read More
Phase 2,3 trial data of India's first mRNA COVID vaccine submitted to DCGI
Updated : 4 years, 2 months ago IST
New Delhi [India], March 18 (ANI): Pune-based Gennova Biopharmaceuticals has submitted the phase-II and phase-III trials data of India's first mRNA COVID vaccine to the regulator Drugs Controller General of India (DCGI) on Friday, said sources.
Read More
India's first homegrown mRNA vaccine to be tested amid Omicron spike: Offi
Updated : 4 years, 4 months ago IST
New Delhi [India], January 17 (ANI): The country's first messenger mRNA vaccine is expected to begin trials on humans in February.
Read More
Study: Small amounts of carbon monoxide may help protect vision in diabete
Updated : 4 years, 6 months ago IST
Washington [US], November 6 (ANI): The Medical College of Georgia scientists have early evidence that HBI-002, a low-dose oral compound developed by Hillhurst Biopharmaceuticals and already in early-stage trials for sickle cell disease, can safely reduce oxidative stress and inflammation in
Read More
Biocon posts Rs 257 crore profit for Q4 on strong biosimilar business
Updated : 5 years ago IST
Bengaluru (Karnataka) [India], April 29 (ANI): Biopharmaceuticals major Biocon Ltd on Thursday reported net profit of Rs 257 crore in the fourth quarter of FY21, up 95 per cent from Rs 132 crore in Q4 FY20.
Read More
Biocon reports 17 pc dip in Q3 net profit at Rs 169 cr
Updated : 5 years, 4 months ago IST
Bengaluru (Karnataka) [India], January 22 (ANI): Biopharmaceuticals major Biocon Ltd has reported 17 per cent decline in its net profit to Rs 169 crore during the quarter ended December while the company's topline grew by 7 per cent to Rs 1,879 crore.
Read More
Biocon Biologics gets Rs 555 crore capital injection from ADQ
Updated : 5 years, 4 months ago IST
Bengaluru (Karnataka) [India], Jan 7 (ANI): Abu Dhabi-based ADQ will invest Rs 555 crore for 1.8 per cent minority stake in Biocon Biologics, valuing it at a post money valuation of 4.17 billion dollars (about Rs 30,482 crore).
Read More